Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950135-05-006955
Filing Date
2005-12-14
Accepted
2005-12-14 11:12:50
Documents
1
Group Members
RA CAPITAL BIOTECH FUND, L.P.RICHARD H. ALDRICH

Document Format Files

Seq Description Document Type Size
1 RA CAPITAL MANAGEMENT, LLC RE: PRAECIS PHARMACEUTICALS b58186rasc13g.htm SC 13G 34745
  Complete submission text file 0000950135-05-006955.txt   36674
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 7817954100
PRAECIS PHARMACEUTICALS INC (Subject) CIK: 0001033025 (see all company filings)

EIN.: 043200305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60009 | Film No.: 051262907
SIC: 2834 Pharmaceutical Preparations

Mailing Address 111 HUNTINGTON AVE, SUITE 610 BOSTON MA 02199
Business Address 111 HUNTINGTON AVE, SUITE 610 BOSTON MA 02199 617-778-2512
RA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001346824 (see all company filings)

EIN.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G